文献速递垂体与肾上腺疾病

药物治�疗库欣病患者持续性轻度高皮质醇血症的证据:Haircush研究

Evidence of Persistent Mild Hypercortisolism in Patients Medically Treated for Cushing Disease: the Haircush Study.
PubMed 文献 · J Clin Endocrinol Metab · 2023-01-01

这项多中心前瞻性研究纳入3组女性患者:16例接受稳定剂量降皮质醇药物且尿游离皮质醇正常的药物治�疗患者、13例垂体手术后治愈患者和15例双侧肾上腺切除后接受稳定推荐剂量氢化可的松替代患者。结果显示,尽管药物治�疗患者尿游离皮质醇几乎均正常,其发皮质醇(HE)仍高于手术治愈对照组(P = .003),且临床评分、尿游离皮质醇、深夜唾液皮质醇及深夜唾液可的松和这些参数的变异性均升高。

要点

  • 药物治�疗库欣病患者尿游离皮质醇正常时,发皮质醇仍高于手术治愈者(P = .003)。
  • 药物治�疗组临床评分(P = .001)、尿游离皮质醇(P = .03)、深夜唾液皮质醇和可的松(P = .0001)及其变异性(P = .004)均升高。
  • 15例药物治�疗患者中6例发皮质醇升高,其降压药剂量高于发皮质醇正常者(P = .05)。

核心结论

  • 尽管尿游离皮质醇正常,部分药物治�疗库欣病患者仍显示血清皮质醇昼夜节律改变。
  • 单次发皮质醇(HE)测量可识别慢性轻度持续性高皮质醇血症,并可能在尿游离皮质醇正常后替代多次唾液分析来监测药物治�疗。

研究设计与样本

  • 多中心前瞻性研究,纳入3组女性患者:药物治�疗组16例(稳定降皮质醇药物剂量且尿游离皮质醇正常)、手术治愈组13例、双侧肾上腺切除后氢化可的松替代组15例(稳定推荐剂量)。
  • 患者按常规治�疗观察3个月,药物治�疗组每月采集2次深夜唾液和24小时尿液样本,手术治愈组和肾上腺切除组在研究结束时采集,所有患者研究结束时采集3厘米头发样本。

主要发现

  • 药物治�疗组尿游离皮质醇几乎均正常,但发皮质醇(HE)高于手术治愈对照组(P = .003)。
  • 药物治�疗组临床评分(P = .001)、尿游离皮质醇(P = .03)、深夜唾液皮质醇和深夜唾液可的松(P = .0001)及其变异性(P = .004)均升高。
  • 肾上腺切除组发皮质醇(HF)和发可的松(HE)升高,而深夜唾液可的松与手术治愈组相似。
  • 15例药物治�疗患者中6例发可的松浓度升高,且其降压药剂量高于发可的松正常的药物治�疗患者(P = .05)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Cortisol-lowering drugs may not restore a normal cortisol secretion in Cushing disease (CD). OBJECTIVE: This work aimed to assess the long-term cortisol exposure in medically treated CD patients using hair-cortisol (HF) and hair-cortisone (HE) measurement. METHODS: This multicenter prospective study included 3 groups of female patients: CushMed = 16 treated with a stable cortisol-lowering drug dosage and normal urinary free cortisol (UFC); CushSurg = 13 cured by pituitary surgery; CushBla = 15 receiving stable recommended doses of hydrocortisone following bilateral adrenalectomy. Patients were evaluated for 3 months with their usual treatments. Two late-night saliva and 24-hour urine samples were collected monthly in CushMed, and at study end in CushSurg and CushBla patients. A 3-cm hair sample was collected at study end from all patients. Main outcome measures included clinical score and centralized measurement of UFC, late-night salivary cortisol (LNSF), late-night salivary cortisone (LNSE), HE, HF. RESULTS: Despite having almost all UFCs normalized, CushMed patients exhibited increased HE as compared to CushSurg controls (P = .003). CushMed patients also had increased clinical score (P = .001), UFC (P = .03), LNSF, LNSE (P = .0001), and variability in the latter parameters (P = .004). CushBla patients had increased HF and HE, contrasting with LNSEs similar to CushSurg patients. Six of 15 CushMed patients exhibited increased HE concentrations and had increased antihypertensive drug dosage compared to CushMed patients with normal HE (P = .05). CONCLUSION: Despite normalized UFCs, a subset of medically treated CD patients displays an altered circadian rhythm of serum cortisol. A single HE measurement identifies chronic mild persistent hypercortisolism and could replace multiple saliva analyzes to monitor medical treatments in CD patients once UFC is normalized.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Mohammedi K, Bertherat J, Raverot G, et al. Evidence of Persistent Mild Hypercortisolism in Patients Medically Treated for Cushing Disease: the Haircush Study. J Clin Endocrinol Metab. 2023. PMID: 37144820. doi:10.1210/clinem/dgad251

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。